HCA Healthcare to Donate up to $400,000 to Kentucky Flood Relief Efforts


Hitesh

HCA Healthcare, Inc., one of the nation’s leading healthcare providers, today announced that it will contribute up to $400,000 in funding, colleague matching, and in-kind donations to support organizations providing relief services to eastern Kentucky communities struck by historic flooding. HCA Healthcare will contribute to the following organizations: $100,000 to […]

Pfizer to Acquire Global Blood Therapeutics for $5.4 Billion to Enhance Presence in Rare Hematology


Hitesh

Global Blood Therapeutics, Inc. (GBT), a biopharmaceutical company dedicated to the discovery, development, and delivery of life-changing treatments that give hope to underserved patient communities, starting with sickle cell disease, and Pfizer Inc., announced today that the two companies have entered into a binding agreement (SCD). The acquisition strengthens the […]

Adventist HealthCare Moving to the Innovaccer Health Cloud to Support Value-Based Whole-Person Care


Hitesh

Adventist HealthCare has chosen Innovaccer as its partner for value-based care and the next generation of population health management, according to an announcement made today by Innovaccer Inc., a Health Cloud company. The Gaithersburg, Maryland-based not-for-profit health services organisation sought to develop a unified data platform to aid in providing […]

GE Healthcare releases next-generation premium fixed X-ray system


Hitesh

The most cutting-edge fixed X-ray system yet from GE Healthcare is the Definium 656 HD. This newest generation of the overhead tube suspension (OTS) system, which leads GE Healthcare’s portfolio of fixed X-ray products, provides consistent, highly automated, efficient exams that instil clinical confidence while streamlining workflow, improving consistency, and […]

Ipsen and Marengo Therapeutics Announce Strategic Partnership to Advance Two Precision Immuno-Oncology Candidates


Hitesh

In order to advance two of Marengo’s preclinical STAR platform-generated candidates into the clinic, Ipsen and Marengo Therapeutics, Inc. today established a collaborative agreement. The partnership will take advantage of Ipsen’s global oncology footprint and Marengo’s in-house R&D experience to develop and commercialise a novel T cell activation mechanism. Ipsen […]

Quanterix Launches First pTau-181 Plasma Laboratory Developed Test for Clinical Diagnostic and Research Applications


Hitesh

A laboratory-developed test (LDT) to quantitatively measure phospho-Tau 181 (pTau-181) in plasma as a help in diagnostic assessment of Alzheimer’s disease has been validated, according to Quanterix Corporation, a business pushing the boundaries of discovery with ultrasensitive biomarker detection (AD). The Quanterix LDT is a quantitative immunoassay designed to determine […]